Jong- Su Kang

Dr. Jong- Su Kang

Dongguk University College of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Biochemical Pharmacology
Verified
Journal Article
Closed access
JKJong- Su Kang
Jong- Su Kang
LNLe Ba Nam
Le Ba Nam
OYOk-Kyung Yoo
Ok-Kyung Yoo
Young-Sam KeumYoung-Sam Keum
Young-Sam Keum

10 September 2018 in Free Radical Research
Verified
Journal Article
Closed access
JLJune Lee
June Lee
JKJong- Su Kang
Jong- Su Kang
LNLe Ba Nam
Le Ba Nam
OYOk-Kyung Yoo
Ok-Kyung Yoo
Young-Sam KeumYoung-Sam Keum
Young-Sam Keum
NF-E2-related factor 2 (NRF2) regulates transcription of phase II cytoprotective enzymes to protect normal cells against oxidative stress. However, a high level of NRF2 offers a growth advantage, chemoresistance, and radioresistance in cancer. In the present study, we have identified convallatoxin as a novel inhibitor of NRF2/ARE. Suppression of NRF2 by convallatoxin was not transcriptionally mediated, but regulated at the level of proteolysis. Convallatoxin activated GSK-3β and suppression of NRF2 by convallatoxin required the Neh6 domain. Convallatoxin sensitised A549 cells to 5-fluorouracil-mediated cell death by promoting apoptosis. Together, our results provide evidence that convallatoxin might be useful as a chemotherapeutic adjuvant due to its ability to suppress NRF2/ARE.

1 August 2019 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
JKJong- Su Kang
Jong- Su Kang
JLJune Lee
June Lee
LNLe Ba Nam
Le Ba Nam
OYOk-Kyung Yoo
Ok-Kyung Yoo
KPKim-Thanh Pham
Kim-Thanh Pham
Young-Sam KeumYoung-Sam Keum
Young-Sam Keum

5 January 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
JKJong- Su Kang
Jong- Su Kang
NLNam Ba Le
Nam Ba Le
OYOk-Kyung Yoo
Ok-Kyung Yoo
KLKyeong Lee
Kyeong Lee
YSYoung-Ah Suh
Young-Ah Suh
Young-Sam KeumYoung-Sam Keum
Young-Sam Keum
KELCH-ECH-associated protein 1 (KEAP1) is an adaptor protein of Cullin 3 (CUL3) E3 ubiquitin ligase that targets a redox sensitive transcription factor, NF-E2-related factor 2 (NRF2). BRCA1-associated protein 1 (BAP1) is a tumor suppressor and deubiquitinase whose mutations increase the risk of several types of familial cancers. In the present study, we have identified that BAP1 deubiquitinates KEAP1 by binding to the BTB domain. Lentiviral transduction of BAP1 decreased the expression of NRF2 target genes, suppressed the migration and invasion, and sensitized cisplatin-induced apoptosis in human lung adenocarcinoma (LUAD) A549 cells. Examination of the lung tissues in KrasG12D/+ mice demonstrated that the level of Bap1 and Keap1 mRNAs progressively decreases during lung tumor progression, and it is correlated with NRF2 activation and the inhibition of oxidative stress. Supporting this observation, lentiviral transduction of BAP1 decreased the growth of A549 xenografts in athymic nude mice. Transcriptome analysis of human lung tissues showed that the levels of Bap1 mRNA are significantly higher in normal samples than LUAD samples. Moreover, the expression of Bap1 mRNA is associated with a better survival of LUAD patients. Together, our study demonstrates that KEAP1 deubiquitination by BAP1 is novel tumor suppressive mechanism of LUAD.

1 November 2016 in Biomolecules & Therapeutics
Verified
Journal Article
Open access
JLJune Lee
June Lee
JKJong- Su Kang
Jong- Su Kang
BCBu-Young Choi
Bu-Young Choi
Young-Sam KeumYoung-Sam Keum
Young-Sam Keum
5-fluorouracil (5-FU) is a chemotherapeutic agent commonly used for treatment of solid tumors, including colorectal cancer. However, chemoresistance against 5-fluorouracil (5-FU) often limits its success for chemotherapy and, therefore, finding out appropriate adjuvant(s) that might overcome chemoresistance against 5-FU bears a significant importance. In the present study, we have found that α-mangostin can sensitize 5-FU-resistant SNUC5/5-FUR colon cancer cells to apoptosis. Exposure of α-mangostin induced significant DNA damages and increased the intracellular 8-hydroxyguanosine (8-OH-G) and 4-hydroxynonenal (4-HNE) levels in SNUC5 and SNUC5/5-FUR cells. Western blot analysis illustrated that α-mangostin-induced apoptosis was mediated by the activation of the extrinsic and intrinsic pathways in SNUC5/5-FUR cells. In particular, we observed that Fas receptor (FasR) level was lower in SNUC5/5-FUR cells, compared with SNUC5 cells and that silencing FasR attenuated α-mangostin-mediated apoptosis in SNUC5/5-FUR cells. Together, our study illustrates that α-mangostin might be an efficient apoptosis sensitizer that can overcome chemoresistance against 5-FU by activating apoptosis pathway.

30 March 2022 in Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
JKJong- Su Kang
Jong- Su Kang
XZXin Yi Zhao
Xin Yi Zhao
Jeong Sang LeeJeong Sang Lee
Jeong Sang Lee
Young-Sam KeumYoung-Sam Keum
Young-Sam Keum
Jong Su Kang, Xin Yi Zhao, Jeong Ho Lee, Jeong-Sang Lee, Young-Sam Keum. J Cancer Prev 2022;27:42-9. https://doi.org/10.15430/JCP.2022.27.1.42